Dr. Lal PathLabs Limited Financial Overview
Dr. Lal PathLabs Limited's market cap is currently ₹236.39B. The company's EPS TTM is ₹18; its P/E ratio is 44.03; and it has a dividend yield of 0.89%. Dr. Lal PathLabs Limited is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is ₹13.19. See an overview of income statement, balance sheet, and cash flow financials.
